查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462358

急性腎損傷治療市場 - 成長、未來前景、競爭分析，2024-2032 年

Acute Kidney Injury Treatment Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

受各種驅動因素和細分方面的影響，預計 2024 年至 2032 年預測期內，急性腎損傷治療市場將以 7.8% 的複合年增長率增長。推動市場成長的三個主要因素包括急性腎損傷盛行率的增加、治療方法的進步以及老年人口的增加。這些因素促成了市場的積極前景，對有效 AKI 治療的需求預計將激增。競爭趨勢、Fresenius Medical Care AG &Co.KGaA、Baxter International Inc. 的策略性舉措（包括研發、合作夥伴關係和技術整合）支撐著充滿活力和不斷發展的市場。這些公司正在對自己進行策略性定位，以應對課題並利用新機遇，塑造急性腎損傷治療市場的未來軌跡。

市場驅動因素

透析技術的進步

由於透析技術的不斷進步，急性腎損傷治療市場的透析部分正在經歷顯著增長。到 2023 年，對更有效率、對患者友善的透析方法的需求將激增。穿戴式和便攜式透析機等技術創新已變得普遍，增加了 AKI 患者獲得治療的機會並提高了生活品質。事實證明，先進透析技術的採用與患者滿意度的提高之間存在正相關關係。

更重視支持性護理

支持性護理已成為急性腎損傷治療市場的關鍵驅動力，滿足了全面患者管理的需求。超越傳統醫療介入措施向整體病患照護的典範轉移促進了支持性照護的興起。到 2023 年，有證據表明，人們越來越認識到社會心理支持、營養干預和症狀管理對於改善 AKI 患者預後的重要性。支持性護理策略不僅可以提高病人的福祉，而且還顯示出成本效益的潛力。

依 AKI 類型細分

基於 AKI 類型（例如腎前性 AKI、原發性腎性 AKI 和腎後性 AKI）的市場區隔在客製化治療方法方面發揮了至關重要的作用。2023 年，腎前性 AKI 領域的收入最高，反映了導致腎臟血流量減少的病理學的流行。同時，基本腎臟 AKI 部分在預測期內顯示出最高的複合年增長率，這意味著對基本腎臟問題的認識和針對性幹預措施有所提高。

AKI 後復原的課題

儘管急性治療的進展值得注意，但市場在 AKI 後的恢復方面面臨重大限制。到 2023 年，證據顯示一些 AKI 患者在實現完全康復和預防慢性腎臟病進展方面取得的成功有限。儘管具有急性治療功效，但長期影響和持續恢復仍然是醫療保健提供者和患者的擔憂和課題。

依治療劃分的市場 透析療法主導市場

市場主要分為透析治療和支持性治療。2023年，透析療法成為主要的治療方式，在2024-2032年的預測期內獲得最高的收入並表現出最高的複合年增長率（CAGR）。透析治療，包括血液透析和腹膜透析，在解決 AKI 相關併發症方面發揮重要作用，並為患者提供了重要的生命線。

依類型劃分的市場：腎前性 AKI 細分市場佔據主導地位

AKI分為不同類型，包括腎前性AKI、原發性腎性AKI及腎後性AKI。腎前性 AKI 是指導致腎臟血流量減少的疾病的盛行率，例如脫水和心臟衰竭，疾病在 2023 年的銷售量最高。同時，重要的腎臟 AKI 領域在預測期內顯示出最高的複合年增長率。這強調提高對急性腎小管壞死等基本腎臟問題的認識和有針對性的干預。

依最終用戶劃分的市場：醫院主導市場

依最終用戶細分包括醫院、門診手術中心 (ASC) 和其他醫療保健環境。到2023年，無論從收入或複合年增長率來看，醫院都已成為主要的最終用戶。醫院在管理急性腎損傷病例、提供專門護理和獲得先進治療方面至關重要。門診手術中心和其他醫療機構在某些情況下也發揮著重要作用，並為 AKI 治療的整體格局做出了貢獻。

北美仍處於世界領先地位

區域細分分析揭示了令人著迷的趨勢，反映了 AKI 盛行率、醫療基礎設施和治療可近性的區域差異。在急性腎損傷治療市場中，亞太地區的複合年增長率最高。這一增長是由於人們認識的提高、醫療保健基礎設施的改善以及導致 AKI 的疾病盛行率的增加。該地區的醫療保健環境充滿活力，將在未來 AKI 治療中發揮重要作用。從銷售比例來看，2023年北美市場將會領先。該地區的主導地位是由大量患者人口、完善的醫療設施以及積極主動的 AKI 管理方法等因素推動的。對於希望利用新機會並應對多元化醫療保健生態系統中的特定課題的利害關係人來說，瞭解區域細微差別至關重要。

預測期內市場競爭將加劇

2023年，急性腎損傷治療市場將包括Fresenius Medical Care AG &Co.KGaA、Baxter International Inc.、B. Braun Melsungen AG、Angion Biomedica Corp.、AM-Pharma、Quark Pharmaceuticals, Inc.、Asahi Kasei Medical、LG Chem等。這些產業巨頭正在策略性地實施研發、聯盟和地理擴張等舉措，以鞏固其市場地位。值得注意的是，Fresenius Medical Care AG &Co.KGaA 專注於尖端技術，而 Baxter International 則專注於以患者為中心的方法。此外，B. Braun Melsungen AG 透過併購和品質改進等策略性舉措為市場動態做出了重大貢獻。這凸顯了動態的市場格局和不斷變化的競爭格局。

本報告回答的關鍵問題

影響急性腎損傷治療市場成長的關鍵微觀和宏觀環境因素有哪些？

在目前和預測期內，有關產品細分和地區的主要投資領域有哪些？

2032 年之前的預估與市場預測

在預測期間內，哪個細分市場的複合年增長率最快？

哪個細分市場擁有較大的市場佔有率，為什麼？

低收入和中等收入國家是否正在投資急性腎損傷治療市場？

急性腎損傷治療市場最大的區域市場是哪一個？

亞太、拉丁美洲、中東/非洲等新興市場的市場趨勢與動態如何？

推動急性腎損傷治療市場成長的主要趨勢是什麼？

主要競爭對手及其提高在全球急性腎損傷治療市場佔有率的關鍵策略是什麼？

目錄

第一章 前言

  • 報告內容
    • 報告目的
    • 目標聽眾
    • 主要報價
  • 市場細分
  • 調查方法
    • 第一階段—二次調查
    • 第二階段-初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採取的方法

第 2 章執行摘要

第三章急性腎損傷治療市場：競爭分析

  • 主要廠商市場定位
  • 供應商採取的策略
  • 主要產業戰略
  • 等級分析：2023 年 vs 2032 年

第四章急性腎損傷治療市場：宏觀分析與市場動態

  • 介紹
  • 2022-2032年全球急性腎損傷治療市場價值
  • 市場動態
    • 市場驅動力
    • 市場制約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析
  • 波特的五力模型
    • 供應商實力
    • 購買力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭對手之間的競爭
  • PESTEL 分析
    • 政局
    • 金融情況
    • 技術景觀
    • 法律狀況
    • 社會局勢

第五章急性腎損傷治療市場：依治療方法分類2022-2032年

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 市場細分
    • 透析
    • 支持性護理

第六章 急性腎損傷治療市場：依類型 2022-2032

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 市場細分
    • 腎前性急性腎損傷
    • 內源性腎性急性腎損傷
    • 腎後性急性腎損傷

第七章 急性腎損傷治療市場：依最終使用者分類 2022-2032

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 市場細分
    • 醫院
    • 門診手術中心
    • 其他

第8章 2022-2032年北美急性腎損傷治療市場

  • 市場概況
  • 急性腎損傷治療市場：依治療方法分類 2022-2032
  • 急性腎損傷治療市場：依類型 2022-2032
  • 急性腎損傷治療市場：依最終使用者分類 2022-2032
  • 急性腎損傷治療市場：依地區劃分 2022-2032
    • 北美
      • 美國
      • 加拿大
      • 其他北美

第9章英國及歐盟急性腎損傷治療市場2022-2032

  • 市場概況
  • 急性腎損傷治療市場：依治療方法分類 2022-2032
  • 急性腎損傷治療市場：依類型 2022-2032
  • 急性腎損傷治療市場：依最終使用者分類 2022-2032
  • 急性腎損傷治療市場：依地區劃分 2022-2032
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 歐洲其他地區

第10章 2022-2032年亞太地區急性腎損傷治療市場

  • 市場概況
  • 急性腎損傷治療市場：依治療方法劃分2022-2032年
  • 急性腎損傷治療市場：依類型 2022-2032
  • 急性腎損傷治療市場：依最終使用者分類 2022-2032
  • 急性腎損傷治療市場：依地區劃分 2022-2032
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區

第十一章拉丁美洲急性腎損傷治療市場2022-2032

  • 市場概況
  • 急性腎損傷治療市場：依治療方法分類 2022-2032
  • 急性腎損傷治療市場：依類型 2022-2032
  • 急性腎損傷治療市場：依最終使用者分類 2022-2032
  • 急性腎損傷治療市場：依地區劃分 2022-2032
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第12章 2022-2032年中東及非洲急性腎損傷治療市場

  • 市場概況
  • 急性腎損傷治療市場：依治療方法分類 2022-2032
  • 急性腎損傷治療市場：依類型 2022-2032
  • 急性腎損傷治療市場：依最終使用者分類 2022-2032
  • 急性腎損傷治療市場：依地區劃分 2022-2032
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第十三章公司簡介

  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Angion Biomedica Corp.
  • AM-Pharma
  • Quark Pharmaceuticals Inc.
  • Asahi Kasei Medical Co. Ltd.
  • LG Chem
  • 其他主要公司
Product Code: 140195-03-24

The acute kidney injury treatment market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032, influenced by various drivers and segmented aspects. Three key drivers fuelling market growth include the increasing prevalence of acute kidney injury, advancements in treatment modalities, and a rising geriatric population. These factors contribute to a positive outlook for the market, with a forecasted surge in demand for effective AKI treatments. Competitive trends showcase the prowess of key players like Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., and B. Braun Melsungen AG. Their strategic initiatives, encompassing research and development, partnerships, and technological integration, underscore a vibrant and evolving market. These companies position themselves strategically to address challenges and capitalize on emerging opportunities, shaping the future trajectory of the Acute kidney injury treatment market.

Key Market Drivers

Advancements in Dialysis Technologies

The dialysis segment of the Acute kidney injury treatment market has experienced substantial growth, attributed to continuous advancements in dialysis technologies. In 2023, the market witnessed a surge in demand for more efficient and patient-friendly dialysis methods. Innovations such as wearable and portable dialysis devices gained traction, enhancing treatment accessibility and improving the quality of life for AKI patients. Evidence suggests a positive correlation between the adoption of advanced dialysis technologies and increased patient satisfaction.

Rising Focus on Supportive Care

Supportive care emerged as a pivotal driver in the Acute kidney injury treatment market, responding to the need for comprehensive patient management. The paradigm shifts towards holistic patient care, beyond traditional medical interventions, contributed to the prominence of supportive care. In 2023, evidence indicated a growing recognition of the importance of psychosocial support, nutritional interventions, and symptom management in improving AKI patient outcomes. Supportive care strategies demonstrated not only enhanced patient well-being but also potential cost-effectiveness.

Segmentation by AKI Type

Market segmentation based on AKI types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI, played a pivotal role in tailoring treatment approaches. In 2023, the highest revenue was observed in the Pre-renal AKI segment, reflecting the prevalence of conditions leading to reduced blood flow to the kidneys. Meanwhile, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, signifying increasing recognition and targeted interventions for intrinsic kidney issues.

Challenges in Post-AKI Recovery

While advancements in acute treatment modalities are notable, the market faces a significant restraint concerning post-AKI recovery. In 2023, evidence pointed towards limited success in achieving complete recovery and preventing chronic kidney disease progression in some patients post-AKI. Despite acute treatment efficacy, the long-term impact and sustainable recovery remain areas of concern, posing challenges for both healthcare providers and patients.

Market by Treatment: Dialysis Dominate the Market

The market is primarily segmented into Dialysis and Supportive Care. In 2023, Dialysis emerged as the dominant treatment modality, capturing both the highest revenue and exhibiting the highest Compound Annual Growth Rate (CAGR) during the forecast period of 2024 to 2032. Dialysis, including hemodialysis and peritoneal dialysis, is instrumental in addressing the immediate complications associated with AKI, providing a crucial lifeline for patients.

Market by Type: Pre-renal AKI Segment Dominate the Market

AKI is classified into various types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI. The Pre-renal AKI segment commanded the highest revenue in 2023, indicating the prevalence of conditions leading to decreased blood flow to the kidneys, such as dehydration or heart failure. Concurrently, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, highlighting the growing recognition and targeted interventions for intrinsic kidney issues, such as acute tubular necrosis.

Market by End-user: Hospitals Dominate the Market

End-user segmentation encompasses Hospitals, Ambulatory Surgical Centers (ASCs), and Other healthcare settings. Hospitals emerged as the leading end-user in 2023, both in terms of revenue and CAGR. The hospital setting is pivotal for managing acute cases of kidney injury, providing specialized care, and access to advanced treatment modalities. Ambulatory Surgical Centers and other healthcare facilities also play crucial roles in specific scenarios, contributing to the overall landscape of AKI treatment.

North America remains the Global Leader

The geographic segment analysis reveals compelling trends, reflecting regional variations in AKI prevalence, healthcare infrastructure, and treatment accessibility. Asia-Pacific demonstrated the highest CAGR in the Acute kidney injury treatment market. This growth is attributed to increased awareness, improved healthcare infrastructure, and a higher prevalence of conditions leading to AKI. The dynamic nature of this region's healthcare landscape positions it as a key player in the future trajectory of AKI treatment. In terms of revenue percentage, North America led the market in 2023. The dominance of this region is fueled by factors such as a large patient population, well-established healthcare facilities, and a proactive approach to AKI management. Understanding the regional nuances is crucial for stakeholders aiming to capitalize on emerging opportunities and address specific challenges in diverse healthcare ecosystems.

Market Competition to Intensify during the Forecast Period

In 2023, the Acute kidney injury treatment market witnessed prominent performances from key players, including Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Asahi Kasei Medical Co., Ltd., and LG Chem. These industry leaders strategically implemented initiatives such as research and development, partnerships, and geographical expansion to reinforce their market positions. Notably, Fresenius Medical Care AG & Co. KGaA emphasized cutting-edge technologies, while Baxter International Inc. focused on patient-centric approaches. Additionally, B. Braun Melsungen AG contributed significantly to market dynamics through strategic initiatives, including mergers and acquisitions and quality improvement. This highlights the vibrant and evolving competitive landscape in the Acute kidney injury treatment market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Kidney Injury Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Acute Kidney Injury Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

    • Dialysis
    • Supportive Care

Type

    • Pre-renal Acute Kidney Injury
    • Intrinsic Renal Acute Kidney Injury
    • Post-renal Acute Kidney Injury

End-User

    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Acute Kidney Injury Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Acute Kidney Injury Treatment market?

Which is the largest regional market for Acute Kidney Injury Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Acute Kidney Injury Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Kidney Injury Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Acute Kidney Injury Treatment Market
  • 2.2. Global Acute Kidney Injury Treatment Market, By Treatment, 2023 (US$ Million)
  • 2.3. Global Acute Kidney Injury Treatment Market, By Type, 2023 (US$ Million)
  • 2.4. Global Acute Kidney Injury Treatment Market, By End-User, 2023 (US$ Million)
  • 2.5. Global Acute Kidney Injury Treatment Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. Acute Kidney Injury Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Acute Kidney Injury Treatment Market Vendors
  • 3.2. Strategies Adopted by Acute Kidney Injury Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Acute Kidney Injury Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Acute Kidney Injury Treatment Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Dialysis
    • 5.3.2. Supportive Care

6. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Pre-renal Acute Kidney Injury
    • 6.3.2. Intrinsic Renal Acute Kidney Injury
    • 6.3.3. Post-renal Acute Kidney Injury

7. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others

8. North America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 8.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 8.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 8.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 9.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 9.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 9.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 10.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 10.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 10.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

11. Latin America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 11.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 11.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 11.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 12.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 12.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 12.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Fresenius Medical Care AG & Co. KGaA
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Baxter International Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. B. Braun Melsungen AG
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Angion Biomedica Corp.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. AM-Pharma
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Quark Pharmaceuticals, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Asahi Kasei Medical Co., Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. LG Chem
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Other Notable Players
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 2 Global Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 3 Global Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 4 North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 5 North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 6 North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 7 U.S. Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 8 U.S. Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 9 U.S. Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 10 Canada Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 11 Canada Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 12 Canada Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 13 Rest of North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 14 Rest of North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 15 Rest of North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 16 UK and European Union Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 17 UK and European Union Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 18 UK and European Union Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 19 UK Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 20 UK Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 21 UK Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 22 Germany Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 23 Germany Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 24 Germany Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 25 Spain Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 26 Spain Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 27 Spain Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 28 Italy Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 29 Italy Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 30 Italy Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 31 France Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 32 France Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 33 France Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 34 Rest of Europe Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 35 Rest of Europe Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 36 Rest of Europe Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 37 Asia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 38 Asia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 39 Asia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 40 China Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 41 China Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 42 China Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 43 Japan Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 44 Japan Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 45 Japan Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 46 India Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 47 India Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 48 India Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 49 Australia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 50 Australia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 51 Australia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 52 South Korea Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 53 South Korea Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 54 South Korea Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 55 Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 56 Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 57 Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 58 Brazil Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 59 Brazil Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 60 Brazil Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 61 Mexico Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 62 Mexico Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 63 Mexico Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 64 Rest of Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 65 Rest of Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 66 Rest of Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 67 Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 68 Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 69 Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 70 GCC Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 71 GCC Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 72 GCC Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 73 Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 74 Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 75 Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Acute Kidney Injury Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Acute Kidney Injury Treatment Market: Quality Assurance
  • FIG. 5 Global Acute Kidney Injury Treatment Market, By Treatment, 2023
  • FIG. 6 Global Acute Kidney Injury Treatment Market, By Type, 2023
  • FIG. 7 Global Acute Kidney Injury Treatment Market, By End-User, 2023
  • FIG. 8 Global Acute Kidney Injury Treatment Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global Acute Kidney Injury Treatment Market, 2023

FIG. 10Market Positioning of Key Acute Kidney Injury Treatment Market Players, 2023

FIG. 11Global Acute Kidney Injury Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 12 Global Acute Kidney Injury Treatment Market, By Treatment, 2023 Vs 2032, %
  • FIG. 13 Global Acute Kidney Injury Treatment Market, By Type, 2023 Vs 2032, %
  • FIG. 14 Global Acute Kidney Injury Treatment Market, By End-User, 2023 Vs 2032, %
  • FIG. 15 U.S. Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 18 UK Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 22 France Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 24 China Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 26 India Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032